Drug discovery and drug enhancement are complex and high-priced endeavors carried out by pharmaceutical businesses, academic scientists, and governments. Because of this intricate path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates by progress pipelines. Drug improvement is the proces